100 related articles for article (PubMed ID: 1355715)
1. Obesity as a risk factor in drug-induced organ injury. V. Toxicokinetics of gentamicin in the obese overfed rat.
Salazar DE; Schentag JJ; Corcoran GB
Drug Metab Dispos; 1992; 20(3):402-6. PubMed ID: 1355715
[TBL] [Abstract][Full Text] [Related]
2. Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat.
Corcoran GB; Salazar DE
J Pharmacol Exp Ther; 1989 Jan; 248(1):17-22. PubMed ID: 2913269
[TBL] [Abstract][Full Text] [Related]
3. Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat.
Corcoran GB; Wong BK
J Pharmacol Exp Ther; 1987 Jun; 241(3):921-7. PubMed ID: 3598908
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin.
Morin NJ; Frau A; Nonclercq D; Toubeau G; Zanen J; Heuson-Stiennon JA; Bergeron MG; Beauchamp D; Laurent G
Exp Mol Pathol; 1994 Jun; 60(3):197-213. PubMed ID: 7525340
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of aminoglycoside nephrotoxicity by vitamin-D-induced hypercalcemia.
Cohen R; Johnson K; Humes HD
Miner Electrolyte Metab; 1988; 14(2-3):121-8. PubMed ID: 3380067
[TBL] [Abstract][Full Text] [Related]
6. Dose response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. III. Effects of dosage adjustment method.
Rogers RA; Hanna AY; Riviere JE
Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):301-11. PubMed ID: 3671882
[TBL] [Abstract][Full Text] [Related]
7. Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats.
Engineer MS; Bodey GP; Newman RA; Ho DH
Drug Metab Dispos; 1987; 15(3):329-34. PubMed ID: 2886307
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
11. Effects of diphenyl-phenylenediamine on gentamicin-induced lipid peroxidation and toxicity in rat renal cortex.
Ramsammy LS; Josepovitz C; Ling KY; Lane BP; Kaloyanides GJ
J Pharmacol Exp Ther; 1986 Jul; 238(1):83-8. PubMed ID: 2873239
[TBL] [Abstract][Full Text] [Related]
12. Effect of methimazole and fish oil treatment on gentamicin nephrotoxicity in rats.
el Daly ES
J Pharm Belg; 1997; 52(4):149-56. PubMed ID: 9316341
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
17. Administration o gentamicin to obese patients.
Korsager S
Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):549-53. PubMed ID: 7228450
[TBL] [Abstract][Full Text] [Related]
18. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
Leader WG; Tsubaki T; Chandler MH
Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
[TBL] [Abstract][Full Text] [Related]
19. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Lane BP; Kaloyanides GJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):149-53. PubMed ID: 2746494
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats.
Dhanarajan R; Abraham P; Isaac B
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):267-72. PubMed ID: 16930301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
